rdf:type |
|
lifeskim:mentions |
umls-concept:C0010186,
umls-concept:C0013557,
umls-concept:C0025266,
umls-concept:C0040771,
umls-concept:C0060389,
umls-concept:C0076107,
umls-concept:C0087111,
umls-concept:C0205081,
umls-concept:C0205082,
umls-concept:C0220812,
umls-concept:C0870071,
umls-concept:C1457887,
umls-concept:C1516048,
umls-concept:C1704272
|
pubmed:issue |
4
|
pubmed:dateCreated |
1995-11-9
|
pubmed:abstractText |
We developed a decision analytic model to compare the costs of treatment for an initial 2-year period with finasteride, terazosin, and transurethral resection of the prostate (TURP) in men with at least moderate symptoms of benign prostatic hyperplasia (BPH). Outcome measures were BPH treatment costs, duration of symptomatic improvement, and lost productivity days (work or other customary activity).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0090-4295
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
477-83
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7571214-Adrenergic alpha-Antagonists,
pubmed-meshheading:7571214-Aged,
pubmed-meshheading:7571214-Decision Trees,
pubmed-meshheading:7571214-Enzyme Inhibitors,
pubmed-meshheading:7571214-Finasteride,
pubmed-meshheading:7571214-Health Care Costs,
pubmed-meshheading:7571214-Humans,
pubmed-meshheading:7571214-Male,
pubmed-meshheading:7571214-Middle Aged,
pubmed-meshheading:7571214-Models, Economic,
pubmed-meshheading:7571214-Prazosin,
pubmed-meshheading:7571214-Prostatectomy,
pubmed-meshheading:7571214-Prostatic Hyperplasia,
pubmed-meshheading:7571214-Severity of Illness Index
|
pubmed:year |
1995
|
pubmed:articleTitle |
Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
|
pubmed:affiliation |
St. Luke's-Roosevelt Hospital Center, Department of Urology, New York, NY 10019, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|